• 

  Cell therapy, gene therapy and tissue-engineered product manufacturing: Technical challenges, enablers and regulatory evolution

  2026-03-04T15:08:00+00:00

• 

  Navigating regulatory pathways for live biotherapeutics in the US and EU: Challenges and opportunities

  2026-03-04T12:15:00+00:00

• 

  New ICH M15 Guideline sets harmonised framework for MIDD

  2026-02-18T11:04:00+00:00

• 

  MHRA points to clinical trial growth and faster assessment routes

  2026-01-28T09:44:00+00:00

• 

  Demystifying complex generic products: Regulatory pathways and characterisation

  2026-01-14T09:52:00+00:00

• 

  Empowering digital innovation in CMC: A framework for regulatory readiness and confidence

  2026-01-14T09:44:00+00:00

• 

  Regulatory challenges and key considerations in the development of radiopharmaceuticals

  2026-01-14T09:41:00+00:00

• 

  Regulatory Rapporteur January 2026 – Contents

  2026-01-13T11:33:00+00:00

• 

  Navigating complexity: Regulation at the interface of innovation, technology and confidence

  2026-01-13T08:19:00+00:00

• 

  A year of change for the US FDA: An update on notable pilots and programmes

  2025-12-15T12:42:00+00:00

• 

  Cross-functional strategies in clinical data disclosure for EMA Policy 0070 and Health Canada PRCI

  2025-12-15T12:41:00+00:00

• 

  From laboratory to patient: The role of New Substance Notifications in delivering innovative therapies in Canada

  2025-12-15T12:40:00+00:00

More pharmaceutical content